ArticleInflammatory bowel diseases2021

Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.

Ruben J Colman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.